Epista Life Science A/S
CVR 32141064 · Public limited company (A/S) · Active · Low risk
Epista Life Science A/S is a Public limited company (A/S), founded on , based in Hørsholm. The company is registered in the industry computerkonsulentbistand og forvaltning af computerfaciliteter. Our model estimates a bankruptcy risk of 0.4% over the next 12 months, which is 0.3 times the average for Danish companies. 17 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 42.8m and a net result of DKK -40.3m.
Bankruptcy risk for Epista Life Science A/S
0.3 × the average (1.41%) · higher risk than 58% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32141064
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (17 years)
- Address
- Slotsmarken 17, 2. th
2970 Hørsholm - Municipality
- Hørsholm
- Industry
- Computerkonsulentbistand og forvaltning af computerfaciliteter (622000)
Bankruptcies in the industry: Konsulentbistand vedrørende informationsteknologi - Share capital
- DKK 530k
- Employees
- 36 (2018)
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 17 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 30.5% |
| Current ratio | 59% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 8 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 104.0m | DKK 80.9m | DKK 76.4m |
| Net profit | DKK -40.3m | DKK -12.5m | DKK 10.5m |
| Equity | DKK 42.8m | DKK 29.3m | DKK 39.0m |
| Total assets | DKK 140.3m | DKK 165.0m | DKK 81.3m |
| Cash | DKK 16.3m | DKK 8.3m | – |
| Short-term debt | DKK 89.8m | DKK 24.3m | – |
| Tax owed | – | DKK 0 | – |
| Avg. employees | 105 | 80 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 182 | ||
| 1 Jan 2023 – 31 Dec 2023 | 151 | ||
| 1 Jan 2022 – 31 Dec 2022 | 152 | ||
| 1 Jan 2021 – 31 Dec 2021 | 130 | ||
| 1 Jan 2020 – 31 Dec 2020 | 119 | ||
| 1 Jan 2019 – 31 Dec 2019 | 107 | ||
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 136 | ||
| 1 Jan 2016 – 31 Dec 2016 | 153 | ||
| 1 Jan 2015 – 31 Dec 2015 | 147 | ||
| 1 Jan 2014 – 31 Dec 2014 | 128 | ||
| 1 Jan 2013 – 31 Dec 2013 | 80 | ||
| 1 Jan 2012 – 31 Dec 2012 | 105 | ||
| 1 Jan 2011 – 31 Dec 2011 | 151 | ||
| 1 Jan 2010 – 31 Dec 2010 | 135 | ||
| 29 Apr 2009 – 31 Dec 2009 | 73 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Martin Woergaard | ||
| CEO | Klavs Esbjerg | ||
| Board | Klavs Esbjerg | Current | |
| Board | Katarína Larsen | Current | |
| Board | Simon Carl Vilhelm Larsson | Current | |
| Board | Mette Pilmann Esbjerg | ||
| Board | Ken Rasmussen | ||
| Board | Knut Ronny Christer Roos | ||
| Board | Line Hyldgaard Hjorth-Christensen | ||
| Board | Maximilian Verfürden Weimann | ||
| Owner (100%) | Enhance BidCo ApS | Current | |
| Owner (5%) | Nikolaj Hørup Vibede | ||
| Owner (5%) | Bobby William Markosfalvi-Barabas Gray | ||
| Owner (67%) | KLAVS ESBJERG HOLDING ApS | ||
| Owner (67%) | Klavs Esbjerg Holding ApS | ||
| Owner (10%) | Pilmann Holding ApS | ||
| Owner (100%) | Enhance BidCo ApS | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | Revision Syd | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Founder | Gloomy Sunday ApS | Current | |
| Founder | KLAVS ESBJERG HOLDING ApS | Current |
The CEOs' other companies
Martin Woergaard – 7 other companies, of which 1 bankrupt
- FORLAGET AUDIENS ApS Bankrupt 14 Dec 1999
- A. Dumas ApS Fusioneret
- BASE life science A/S Active
- Gloomy Sunday ApS Active
- Malpha Enterprise ApS Active
- TPA Capital ApS Active
- TPA Solutions ApS Active
Klavs Esbjerg – 4 other companies
- Enhance TopCo ApS Active
- Genau & More A/S Fusioneret
- KLAVS ESBJERG HOLDING ApS Fusioneret
- TriCore Solutions ApS Active
Address history (3 moves)
| Slotsmarken 17, 2. th, 2970 Hørsholm | |
| Slotsmarken 17, 2. th, 2970 Hørsholm | |
| Slotsmarken 15, 1. th, 2970 Hørsholm | |
| Krakasvej 17, 3400 Hillerød |
Former names
| Epista Life Science A/S | – now |
| EPISTA IT A/S | – |
| EPISTA IT ApS | – |
Employees per year
Other companies at the same address
- Cusaco Holding. ApS Active
- Darkwater ApS Active
- EPISTA AUTOMATION TECHNOLOGIES ApS Fusioneret
- Enhance BidCo ApS Active
- Enhance TopCo ApS Active
- KLAVS ESBJERG HOLDING ApS Fusioneret
- RAW IT ApS Active
- SKY QA-Consulting IVS Compulsorily dissolved
Similar companies in Hørsholm
- REDnexus ApS Hørsholm
- Improvement People.dk ApS Rungsted Kyst
- Hammer & Lorentzen ApS Hørsholm
- JVE Consulting ApS Hørsholm
- Corescale ApS Rungsted Kyst
- AldVidar ApS Hørsholm
- Medvirk ApS Hørsholm
- Elktronic ApS Rungsted Kyst
- Dag ind og dag ud ApS Rungsted Kyst
- Mimetrics ApS Hørsholm
- mgrade-audio ApS Rungsted Kyst
- Wendila Consulting ApS Hørsholm
Questions and answers about Epista Life Science A/S
Has Epista Life Science A/S gone bankrupt?
No, Epista Life Science A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Epista Life Science A/S?
Our model estimates a bankruptcy risk of 0.4% over the next 12 months (low risk), which is 0.3 times the average for Danish companies.
Who is the auditor of Epista Life Science A/S?
Epista Life Science A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Epista Life Science A/S founded?
Epista Life Science A/S was founded on 29 April 2009.
What is the equity of Epista Life Science A/S?
Equity was DKK 42.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.